These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 23892687

  • 1. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
    Kim H, Kim JE, Hwang SM, Lee HR, Han KS, Kim HK.
    Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
    [Abstract] [Full Text] [Related]

  • 2. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ, Joshi A, Schwartz S, Meister JA, Goldberg JW.
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [Abstract] [Full Text] [Related]

  • 3. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS, Gu J, Park HS, Yoo HJ, Kim HK.
    Clin Chem Lab Med; 2017 May 01; 55(6):882-889. PubMed ID: 28002027
    [Abstract] [Full Text] [Related]

  • 4. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T.
    Arthritis Rheum; 2000 Sep 01; 43(9):1982-93. PubMed ID: 11014348
    [Abstract] [Full Text] [Related]

  • 5. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N, Alessi MC, Dignat-George F, Vague IJ, Sampol J, Harlé JR, Sanmarco M.
    Immunobiology; 2007 Sep 01; 212(7):557-65. PubMed ID: 17678713
    [Abstract] [Full Text] [Related]

  • 6. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170
    [Abstract] [Full Text] [Related]

  • 7. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N, Bentow C, Rubio L, Norman GL, López-Sañudo S, Mahler M, Pérez-Isidro A, Cervera R, Viñas O, Espinosa G, Ruiz-Ortiz E.
    Front Immunol; 2021 Dec 15; 12():754469. PubMed ID: 34790198
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E, Darnige L, Kirilovsky A, Burnel Y, de Luna G, Dragon-Durey MA.
    Front Immunol; 2018 Dec 15; 9():2971. PubMed ID: 30619328
    [Abstract] [Full Text] [Related]

  • 9. Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies interfere with cleavage of factor V(a) by activated protein C.
    Noordermeer T, Chemlal S, Jansma JJ, van der Vegte V, Schutgens REG, Limper M, de Groot PG, Meijers JCM, Urbanus RT.
    J Thromb Haemost; 2023 Sep 15; 21(9):2509-2518. PubMed ID: 37290588
    [Abstract] [Full Text] [Related]

  • 10. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A, Ruffatti A, Mattia E, Meneghel L, Tonello M, Salvan E, Pengo V, Punzi L.
    Clin Chem Lab Med; 2015 Jul 15; 53(8):1265-70. PubMed ID: 25562605
    [Abstract] [Full Text] [Related]

  • 11. Double positivity of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies enhances both thrombosis and positivity of anti-ADAMTS13 antibody.
    Yun J, Gu J, Kim HK.
    J Thromb Thrombolysis; 2021 Nov 15; 52(4):1133-1136. PubMed ID: 33914240
    [Abstract] [Full Text] [Related]

  • 12. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y.
    Thromb Haemost; 2004 May 15; 91(5):967-76. PubMed ID: 15116258
    [Abstract] [Full Text] [Related]

  • 13. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 15; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 14. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P, Podovšovnik A, Ambrožič A, Tomšič M, Hočevar A, Gašperšič N, Rotar Ž, Praprotnik S, Šemrl SS, Čučnik S.
    Clin Rheumatol; 2019 Feb 15; 38(2):371-378. PubMed ID: 30099654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.
    Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.
    Arthritis Care Res (Hoboken); 2018 Apr 15; 70(4):627-634. PubMed ID: 28686816
    [Abstract] [Full Text] [Related]

  • 18. Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy.
    Kaneko K, Mishima S, Goto M, Mitsui M, Tanigaki S, Oku K, Ozawa N, Inoue E, Atsumi T, Sago H, Murashima A.
    Mod Rheumatol; 2018 Jul 15; 28(4):670-675. PubMed ID: 29067844
    [Abstract] [Full Text] [Related]

  • 19. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May 15; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 20. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.
    Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F, Andreoli L, Lazzaroni MG, Piantoni S, Masneri S, Crisafulli F, Brugnoni D, Muiesan ML, Salvetti M, Parati G, Torresani E, Mahler M, Heilbron F, Pregnolato F, Pengo M, Tedesco F, Pozzi N, Meroni PL.
    Front Immunol; 2020 May 15; 11():584241. PubMed ID: 33178218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.